Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
U.S. FDA to decide whether to authorize a booster dose in the coming days
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company plans to submit the IND application by the end of 2021
Subscribe To Our Newsletter & Stay Updated
